Both in Pharmaceuticals
Citius Oncology vs Rein Therapeutics
Over the past year CTOR returned −68.0% and RNTX returned −56.8%; their daily moves had a correlation of 0.07.
CTOR −68.0% RNTX −56.8%Growth of $1, one year, split-adjusted
| Metric | CTOR | RNTX |
|---|---|---|
| Price | $0.5540 | $0.6700 |
| Market cap | $58.6M | $57.8M |
| Today | +4.63% | −7.79% |
| 1 month | −43.5% | −21.4% |
| 6 months | −41.4% | −35.0% |
| Year to date | −44.6% | −42.2% |
| 1 year | −68.3% | −56.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | 67.1% | — |
| Net margin | −597.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.2× | — |
| Net cash | $10.2M | $40.6M |
| Dividend yield | — | — |
| Volatility (60d) | 96.7% | 95.3% |
| Short % of float | 0.8% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).